Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19.
Source check: Source checked. Not independent scientific confirmation.
Finding: It identifies 11 host proteins and specific multi-protein panels associated with severity/outcomes; e.g. a four-protein panel discriminated severity groups and a three-protein combination predicted severe/fatal outcome. Five-fold CV plus a separate proteomics cohort (n=26) and ELISA validation in additional samples. The article notes limited early-pandemic sample sizes and says biomarker mechanisms and therapeutic relevance require further work.
Technology: POC-19 uses penalized logistic regression with LASSO/ridge penalties to rank biomarker combinations from plasma proteomics.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- POC-19 uses penalized logistic regression with LASSO/ridge penalties to rank biomarker combinations from plasma proteomics.
- Test and result
- It identifies 11 host proteins and specific multi-protein panels associated with severity/outcomes; e.g. a four-protein panel discriminated severity groups and a three-protein combination predicted severe/fatal outcome.
- Limitation / still unknown
- Five-fold CV plus a separate proteomics cohort (n=26) and ELISA validation in additional samples. The article notes limited early-pandemic sample sizes and says biomarker mechanisms and therapeutic relevance require further work.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC7574896/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Full primary PMC article reviewed. The authors used plasma proteomics and their machine-learning POC-19 pipeline (penalized logistic regression with LASSO/ridge) to select protein biomarker combinations for COVID-19 severity/outcome; results were evaluated in a separate plasma cohort and by ELISA in another cohort. First online 2020-10-20. Neither catalog snapshot contains this DOI/title or the same POC-19 biomarker result..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.